Impact of Breast Cancer Molecular Subtypes on Locoregional Recurrence in Patients Treated with Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

被引：0
作者：
Michael O. Meyers
Nancy Klauber-DeMore
David W. Ollila
Keith D. Amos
Dominic T. Moore
Amy A. Drobish
Emily M. Burrows
E. Claire Dees
Lisa A. Carey
机构：
[1] University of North Carolina School of Medicine at Chapel Hill,Division of Surgical Oncology, Department of Surgery
[2] University of North Carolina School of Medicine at Chapel Hill,Division of Medical Oncology, Department of Medicine
[3] University of North Carolina School of Medicine at Chapel Hill,The Lineberger Comprehensive Cancer Center
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Breast Cancer; Estrogen Receptor; Trastuzumab; Advanced Breast Cancer; Distant Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2851 / 2857
页数：6
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy in locally advanced breast cancer:: a preliminary report
    Baltali, E
    Günel, N
    Onat, DA
    Atahan, IL
    Akcali, Z
    Büyükünal, E
    Aktan, G
    Firat, D
    2ND BALKAN CONGRESS OF ONCOLOGY, 1999, : 185 - 195
  • [22] The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer
    Sauven, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (18) : 2371 - 2374
  • [23] Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer
    Moll, UM
    Chumas, J
    PATHOLOGY RESEARCH AND PRACTICE, 1997, 193 (03) : 187 - 196
  • [24] Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients
    Yildirim, Cigdem
    Teker, Fatih
    Okten, Ilker Nihat
    Gulturk, Ilkay
    Aytekin, Aydin
    Aytekin, Alper
    Yilmaz, Latif
    Afsar, cigdem Usul
    ISTANBUL MEDICAL JOURNAL, 2024, 25 (04): : 274 - 280
  • [25] Locoregional Management of Breast Cancer Following Neoadjuvant Chemotherapy
    Marumoto, Ashley D.
    Giuliano, Armando E.
    CURRENT BREAST CANCER REPORTS, 2022, 14 (04) : 103 - 112
  • [26] Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials
    Werutsky, Gustavo
    Untch, Michael
    Hanusch, Claus
    Fasching, Peter A.
    Blohmer, Jens-Uwe
    Seiler, Sabine
    Denkert, Carsten
    Tesch, Hans
    Jackisch, Christian
    Gerber, Bernd
    Schneeweiss, Andreas
    Link, Theresa
    Krug, David
    Huober, Jens
    Rhiem, Kerstin
    Kuehn, Thorsten
    Vladimirova, Valentina
    Nekljudova, Valentina
    Loibl, Sibylle
    EUROPEAN JOURNAL OF CANCER, 2020, 130 : 92 - 101
  • [27] Locoregional Management of Breast Cancer Following Neoadjuvant Chemotherapy
    Ashley D. Marumoto
    Armando E. Giuliano
    Current Breast Cancer Reports, 2022, 14 : 103 - 112
  • [28] Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study
    Gillon, Pauline
    Touati, Nathan
    Breton-Callu, Christel
    Slaets, Leen
    Cameron, David
    Bonnefoi, Herve
    EUROPEAN JOURNAL OF CANCER, 2017, 79 : 226 - 234
  • [29] Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy
    Boidot, Romain
    Vegran, Frederique
    Lizard-Nacol, Sarab
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 23 (02) : 285 - 291
  • [30] Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis
    Jonathan Klein
    William Tran
    Elyse Watkins
    Danny Vesprini
    Frances C. Wright
    Nicole J. Look Hong
    Sonal Ghandi
    Alex Kiss
    Gregory J. Czarnota
    BMC Cancer, 19
12345